Summit Global Investments’s Phibro Animal Health PAHC Stock Holding History

Summit Global Investments’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$344K	Buy	+10,958	New	+$462K	0.02%	420
2025 Q2	–	Sell	-37,989	Closed	-$811K	–	509
2025 Q1	$811K	Buy	37,989 +10,808	+40%	+$242K	0.06%	203
2024 Q4	$571K	Buy	+27,181	New	+$629K	0.04%	330
2019 Q3	–	Sell	-25,700	Closed	-$816K	–	291
2019 Q2	$816K	Buy	25,700 +2,200	+9%	+$69K	0.1%	125
2019 Q1	$776K	Buy	+23,500	New	+$731K	0.1%	128
2018 Q4	–	Sell	-14,500	Closed	-$622K	–	298
2018 Q3	$622K	Hold	14,500	–	–	0.08%	230
2018 Q2	$668K	Sell	14,500 -900	-6%	-$39.8K	0.1%	173
2018 Q1	$611K	Sell	15,400 -200	-1%	-$7.41K	0.1%	134
2017 Q4	$523K	Buy	+15,600	New	+$554K	0.08%	225

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Summit Global Investments's PAHC Position: Q2 2026 in Review

Summit Global Investments opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 10,958 shares worth $344K. The stake represents 0.02% of the portfolio and ranks #420 among its holdings. This is a return to the name: Summit Global Investments previously reported a position in PAHC as recently as Q1 2025.

Summit Global Investments first reported a position in PAHC in Q4 2017 and has held it in 9 quarters since. The position peaked at $816K in Q2 2019. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Summit Global Investments held 10,958 shares of Phibro Animal Health worth $344K as of Q2 2026.
Phibro Animal Health was a new Summit Global Investments position in Q2 2026.
Phibro Animal Health made up 0.02% of Summit Global Investments's portfolio in Q2 2026, its #420 holding.
Summit Global Investments first reported a position in Phibro Animal Health in Q4 2017 and has held it in 9 quarters since.
Summit Global Investments's Phibro Animal Health position peaked at $816K in Q2 2019.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.